Involvement of IL–6 in the pathogenesis of inflammatory bowel disease and colon cancer

Inflammatory Bowel Disease

Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,183 · see citing works

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

Eaden, J., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,948 · see citing works

Inflammatory bowel disease: Etiology and pathogenesis

Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059 · see citing works

Ulcerative Colitis and Colorectal Cancer

Ekbom, A., Helmick, C. G., Zack, M. M., & Adami, H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231802 · Cited by 1,794 · see citing works

Impaired immune and acute-phase responses in interleukin-6-deficient mice

Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768 · see citing works

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396 · see citing works

Antibodies to interleukin 12 abrogate established experimental colitis in mice.

Neurath, M., Fuss, I. J., Kelsall, B. L., Stuber, E. R., & Strober, W. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.5.1281 · Cited by 1,334 · see citing works

Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo

Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293 · see citing works

Inflammatory Bowel Disease

Podolsky, D. K. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251306 · Cited by 1,228 · see citing works

Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5

Fuss, I. J., Neurath, M. F., Boirivant, M., Klein, J. S., de la Motte, C., Strong, S. A., Fiocchi, C., & Strober, W. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.1261 · Cited by 1,227 · see citing works

Annual Report to the Nation on the Status of Cancer, 1975-2000, Featuring the Uses of Surveillance Data for Cancer Prevention and Control

Weir, H. K. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg040 · Cited by 864 · see citing works

Enhand secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn's disease

REINECKER, H.-C., STEFFEN, M., Witthoeft, T., Pflüger, I., Schreiber, S., MacDermott, R. P., & Raedler, A. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05997.x · Cited by 855 · see citing works

Soluble receptors for cytokines and growth factors: generation and biological function

Rose‐John, S., & Heinrich, P. C. (1994) · Biochemical Journal · doi:10.1042/bj3000281 · Cited by 784 · see citing works

TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling

Becker, C., Fantini, M. C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.020 · Cited by 726 · see citing works

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn’s disease

van den Brande, J. M. H., Braat, H., BRINK, G. R. V. D., Versteeg, H. H., Bauer, C. A., Hoedemaeker, I., van Montfrans, C., Hommes, D. W., Peppelenbosch, M. P., & van Deventer, S. J. H. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00382-2 · Cited by 722 · see citing works

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease☆

Ito, H., Takazoe, M., Fukuda, Y., Hibi, T., Kusugami, K., Andoh, A., Matsumoto, T., Yamamura, T., Azuma, J., & Nishimoto, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.012 · Cited by 636 · see citing works

Intestinal permeability and the prediction of relapse in Crohn's disease

Wyatt, J., Vogelsang, H., Hübl, W., Waldhoer, T., & Lochs, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)90882-h · Cited by 626 · see citing works

The role of Th1/Th2 polarization in mucosal immunity

Neurath, M. F., Finotto, S., & Glimcher, L. H. (2002) · Nature Medicine · doi:10.1038/nm0602-567 · Cited by 623 · see citing works

Cytokines in intestinal inflammation: Pathophysiological and clinical considerations

Sartor, R. B. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90614-9 · Cited by 595 · see citing works

Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells

Monteleone, G., Biancone, L., Marasco, R., Morrone, G., Marasco, O., Luzza, F., & Pallone, F. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70128-8 · Cited by 571 · see citing works

Crohn's disease

Shanahan, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07284-7 · Cited by 478 · see citing works

IL-6 is required for the development of Th1 cell-mediated murine colitis

Yamamoto, M., Yoshizaki, K., Kishimoto, T., & Ito, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4878 · Cited by 411 · see citing works

Intestinal cancer risk and mortality in patients with Crohn's disease

Munkholm, P., Langholz, E., Davidsen, M., & Binder, V. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)91068-s · Cited by 379 · see citing works

Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins

Mackiewicz, A. A., Schooltink, H., Heinrich, P. C., & Rose‐John, S. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.6.2021 · Cited by 369 · see citing works

Serum interleukin‐6 levels reflect the disease status of colorectal cancer

Chung, Y., & Chang, Y. (2003) · Journal of Surgical Oncology · doi:10.1002/jso.10269 · Cited by 354 · see citing works

Resistance of Crohn’s Disease T Cells to Multiple Apoptotic Signals Is Associated with a Bcl-2/Bax Mucosal Imbalance

Ina, K., Itoh, J., Fukushima, K., Kusugami, K., Yamaguchi, T., Kyokane, K., Imada, A., Binion, D. G., Musso, A., West, G. A., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.1081 · Cited by 344 · see citing works

Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification

Isaacs, K. L., Sartor, R. B., & Haskill, S. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91182-4 · Cited by 320 · see citing works

Development of chronic colitis is dependent on the cytokine MIF

de Jong, Y. P., Abadía‐Molina, A. C., Satoskar, A. R., Clarke, K., Rietdijk, S. T., Faubion, W. A., Mizoguchi, E., Metz, C. N., Sahli, M. A., ten Hove, T., et al. (2001) · Nature Immunology · doi:10.1038/ni720 · Cited by 305 · see citing works

Evidence for continuous stimulation of interleukin-6 production in Crohn's disease

Groß, V., Andus, T., Caesar, I., Roth, M., & Schölmerich, J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90098-j · Cited by 293 · see citing works

Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis

Boirivant, M., Marini, M., Felice, G. D., Pronio, A., Montesani, C., Tersigni, R., & Strober, W. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70177-0 · Cited by 267 · see citing works

Prognostic Significance of Circulating IL-10 and IL-6 Serum Levels in Colon Cancer Patients Undergoing Surgery

Galizia, G., Orditura, M., Romano, C. P., Lieto, E., Castellano, P., Pelosio, L., Imperatore, V., Catalano, G., Pignatelli, C., & Vita, F. D. (2002) · Clinical Immunology · doi:10.1006/clim.2001.5163 · Cited by 228 · see citing works

Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease

Desreumaux, P., Brandt, E. B., Gambiez, L. P., Émilie, D., Geboes, K., Klein, O., Ectors, N., Cortot, A., Capron, M., & Colombel, J.-F. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70116-1 · Cited by 219 · see citing works

C-reactive Protein: A Physiological Activator of Interleukin 6 Receptor Shedding

Jones, S. A., Novick, D., Horiuchi, S., Yamamoto, N., Szalai, A. J., & Fuller, G. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.599 · Cited by 196 · see citing works

Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6.

Mitsuyama, K., Toyonaga, A., Sasaki, E., Ishida, O., Ikeda, H., Tsuruta, O., Harada, K., Tateishi, H., Nishiyama, T., & Tanikawa, K. (1995) · Gut · doi:10.1136/gut.36.1.45 · Cited by 185 · see citing works

High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis.

Mahida, Y. R., Kurlac, L., Gallagher, A., & Hawkey, C. J. (1991) · Gut · doi:10.1136/gut.32.12.1531 · Cited by 184 · see citing works

Tissue cytokine and chemokine expression in inflammatory bowel disease

McCormack, G. W., Moriarty, D. C., O’Donoghue, D., McCormick, P. A., Sheahan, K. D., & Baird, A. W. (2001) · Inflammation Research · doi:10.1007/pl00000223 · Cited by 181 · see citing works

Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis

Ishiguro, Y. (1999) · Journal of Gastroenterology · doi:10.1007/s005350050218 · Cited by 175 · see citing works

Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells.

Schneider, M. R., Hoeflich, A., Fischer, J. R., Wolf, E., Sordat, B., & Lahm, H. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00401-2 · Cited by 167 · see citing works

Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent

Kusugami, K., Fukatsu, A., Tanimoto, M., Shinoda, M., Haruta, J.-I., Kuroiwa, A., Ina, K., Kanayama, K., Ando, T., Matsuura, T., et al. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02064182 · Cited by 151 · see citing works

Clinical relevance of serum interleukin-6 in Crohn’s disease: single point measurements, therapy monitoring, and prediction of clinical relapse

Reinisch, W., Gasché, C., Tillinger, W., Wyatt, J., Lichtenberger, C., Willheim, M., Dejaco, C., Waldhör, T., Bakos, S., Vogelsang, H., et al. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01288.x · Cited by 150 · see citing works

Relationship of functional and antigenic interleukin 6 to disease activity in inflammatory bowel disease

Hyams, J. S., Fitzgerald, J. E., Treem, W. R., Wyzga, N., & Kreutzer, D. L. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90336-b · Cited by 146 · see citing works

Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation.

Cappello, M., Keshav, S., Prince, C., Jewell, D. P., & Gordon, S. (1992) · Gut · doi:10.1136/gut.33.9.1214 · Cited by 134 · see citing works

Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease

Itoh, J. (2001) · Gut · doi:10.1136/gut.49.1.35 · Cited by 130 · see citing works

Interleukin-6 and soluble interleukin-6 receptor in the colonic mucosa of inflammatory bowel disease

Hosokawa, T., Kusugami, K., Ina, K., Ando, T., Shinoda, M., Imada, A., Ohsuga, M., Sakai, T., Matsuura, T., Ito, K., et al. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01989.x · Cited by 112 · see citing works

Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6

Daig, R., Rogler, G., Aschenbrenner, E., Vogl, D., Falk, W., Gross, V., Schölmerich, J., & Andus, T. (2000) · Gut · doi:10.1136/gut.46.3.350 · Cited by 104 · see citing works

Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide.

Walev, I., Vollmer, P., Palmer, M., Bhakdi, S., & Rose‐John, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7882 · Cited by 102 · see citing works

A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn??s disease

Louis, E. J., Bélaïche, J., Kemseke, C. V., Franchimont, D. P., Groote, D. D., Gueenen, V., & Mary, J. (1997) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199710000-00004 · Cited by 101 · see citing works

Novel pathogenic mechanism of microbial metalloproteinases: liberation of membrane-anchored molecules in biologically active form exemplified by studies with the human interleukin-6 receptor

Vollmer, P., Walev, I., Rose‐John, S., & Bhakdi, S. (1996) · Infection and Immunity · doi:10.1128/iai.64.9.3646-3651.1996 · Cited by 98 · see citing works

Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.

Mazlam, M. Z., & Hodgson, H. J. F. (1994) · Gut · doi:10.1136/gut.35.1.77 · Cited by 90 · see citing works

Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission

Kemseke, C. V., Bélaïche, J., & Louis, E. J. (2000) · International Journal of Colorectal Disease · doi:10.1007/s003840000226 · Cited by 72 · see citing works

Lamina propria and circulating interleukin-6 in newly diagnosed pediatric inflammatory bowel disease patients

Brown, K. A., Back, S. J., Ruchelli, E. D., Markowitz, J. E., Mascarenhas, M. R., Verma, R., Piccoli, D. A., & Baldassano, R. N. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.06030.x · Cited by 54 · see citing works

Bax is downregulated in inflamed colonic mucosa of ulcerative colitis

Iimura, M., Nakamura, T., Shinozaki, S., Iizuka, B., Inoue, Y., Suzuki, S., & Hayashi, N. (2000) · Gut · doi:10.1136/gut.47.2.228 · Cited by 53 · see citing works

Cytokine messenger RNA expression and proliferation status of intestinal mononuclear cells in noninflamed gut and Crohn's disease

Autschbach, F., Qiao, L., Wallich, R., Meuer, S. C., Sch�rmann, G., & Merz, H. (1995) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00194698 · Cited by 53 · see citing works

The expanding role of biological agents in the treatment of inflammatory bowel disease – focus on selective adhesion molecule inhibition

Rutgeerts, P., van Deventer, S., & Schreiber, S. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01603.x · Cited by 41 · see citing works

Increased interleukin-6 levels, interleukin-6 receptor and gp130 expression in peripheral lymphocytes of patients with inflammatory bowel disease.

Holub, M., Makó, E., Dévay, T., Dank, M., Szalai, C., Fenyvesi, A., & Falus, A. (1998) · PubMed · Cited by 35 · see citing works

Protective and pathogenic roles of cytokines in inflammatory bowel diseases.

Mf, N., & Büschenfelde, K. H. M. Z. (1996) · PubMed · Cited by 19 · see citing works

Mucosal Interleukin-6 Secretion in Ulcerative Colitis: Effects of Anti-Inflammatory Drugs and T-Cell Stimulation

Jones, S., Crabtree, J. E., Rembacken, B. J., Dixon, M. F., Trejdosiewicz, L. K., Hicher, J. T., & Axon, A. T. R. (1994) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529409092500 · Cited by 14 · see citing works

Inflammation and Colon Cancer

Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974 · see citing works

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155 · see citing works

Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.

Yao, X., Huang, J.-Q., Zhong, H., Shen, N., Faggioni, R., Fung, M., & Yao, Y. (2014) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2013.09.004 · Cited by 656 · see citing works

Induction of Osteogenesis in Mesenchymal Stem Cells by Activated Monocytes/Macrophages Depends on Oncostatin M Signaling

Guihard, P. J., Danger, Y., Royer, B. B.-L., David, E., Brion, R., Delécrin, J., Richards, C. D., Chevalier, S., Rédiní, F., Heymann, D., et al. (2012) · Stem Cells · doi:10.1002/stem.1040 · Cited by 477 · see citing works

Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage

Grivennikov, S. I., & Karin, M. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.140145 · Cited by 560 · see citing works

Tumor exosomes inhibit differentiation of bone marrow dendritic cells

Yu, S., Liu, C., Su, K., Wang, J., Liu, Y., Zhang, L., Li, C., Cong, Y., Kimberly, R., Grizzle, W. E., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6867 · Cited by 425 · see citing works

Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.

Triantafillidis, J. K., Nasioulas, G., & Kosmidis, P. (2009) · PubMed · Cited by 425 · see citing works

IL-6 Regulates Neutrophil Trafficking during Acute Inflammation via STAT3

Fielding, C. A., McLoughlin, R. M., McLeod, L., Colmont, C. S., Najdovska, M., Grail, D., Ernst, M., Jones, S. A., Topley, N., & Jenkins, B. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.2189 · Cited by 401 · see citing works

Cytokines and Chemokines inMycobacterium tuberculosisInfection

Domingo-Gonzalez, R., Prince, O. A., Cooper, A. M., & Khader, S. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0018-2016 · Cited by 413 · see citing works

Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases

Soufli, I., Toumi, R., Rafa, H., & Touil–Boukoffa, C. (2016) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v7.i3.353 · Cited by 344 · see citing works

Interleukin‐6 and its receptor in cancer: Implications for Translational Therapeutics

Hong, D. S., Angelo, L. S., & Kurzrock, R. (2007) · Cancer · doi:10.1002/cncr.22999 · Cited by 370 · see citing works

The IL-6/JAK/STAT3 pathway: Potential therapeutic strategies in treating colorectal cancer

Wang, S., & Sun, Y. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2259 · Cited by 321 · see citing works

New fronts emerge in the influenza cytokine storm

Guo, X.-Z. J., & Thomas, P. G. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0636-y · Cited by 295 · see citing works

Cytokines, Inflammation and Colon Cancer

Klampfer, L. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911795538066 · Cited by 290 · see citing works

Interleukin (IL) 1β Induction of IL-6 Is Mediated by a Novel Phosphatidylinositol 3-Kinase-dependent AKT/IκB Kinase α Pathway Targeting Activator Protein-1

Cahill, C. M., & Rogers, J. T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707692200 · Cited by 254 · see citing works

Cytokine patterns in cancer patients: a review of the correlation between interleukin 6 and prognosis

Lippitz, B. E., & Harris, R. A. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1093722 · Cited by 248 · see citing works

MicroRNA-124 Regulates STAT3 Expression and Is Down-regulated in Colon Tissues of Pediatric Patients With Ulcerative Colitis

Κούκος, Γ., Polytarchou, C., Kaplan, J. L., Morley-Fletcher, A., Gras-Miralles, B., Kokkotou, E. G., Baril‐Dore, M., Pothoulakis, C., Winter, H. S., & Iliopoulos, D. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.001 · Cited by 232 · see citing works

A Novel Mouse Model of Inflammatory Bowel Disease Links Mammalian Target of Rapamycin-Dependent Hyperproliferation of Colonic Epithelium to Inflammation-Associated Tumorigenesis

Deng, L., Zhou, J.-F., Sellers, R. S., Li, J.-F., Nguyen, A., Wang, Y., Orlofsky, A., Liu, Q., Hume, D. A., Pollard, J. W., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090622 · Cited by 228 · see citing works

Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice

Sánchez‐Fidalgo, S., Cárdeno, A., Villegas, I., Talero, E., & Alarcón‐de‐la‐Lastra, C. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.01.025 · Cited by 217 · see citing works

Exploiting bacteria for cancer immunotherapy

Kwon, S. Y., Ngo, H. T.-T., Son, J., Hong, Y., & Min, J.-J. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00908-9 · Cited by 220 · see citing works

Risk of Arterial Thrombotic Events in Inflammatory Bowel Disease

Ha, C. Y., Magowan, S., Accortt, N., Chen, J., & Stone, C. (2009) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.81 · Cited by 231 · see citing works

Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders

Srivastava, S. K., Yadav, U. C. S., Reddy, A. B. M., Saxena, A., Tammali, R., Shoeb, M., Ansari, N. H., Bhatnagar, A., Petrash, M. J., Srivastava, S., et al. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.02.023 · Cited by 208 · see citing works

Oxidative stress in ulcerative colitis: an old concept but a new concern

Jena, G., Trivedi, P. P., & Sandala, B. (2012) · Free Radical Research · doi:10.3109/10715762.2012.717692 · Cited by 177 · see citing works

Hen Egg Lysozyme Attenuates Inflammation and Modulates Local Gene Expression in a Porcine Model of Dextran Sodium Sulfate (DSS)-Induced Colitis

Lee, M., Kovacs-Nolan, J., Yang, C., Archbold, T. L., Fan, M. Z., & Mine, Y. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf803133b · Cited by 153 · see citing works

The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer

Luo, C., & Zhang, H. (2017) · Mediators of Inflammation · doi:10.1155/2017/5126048 · Cited by 150 · see citing works

Structural characteristics of steamed Polygonatum cyrtonema polysaccharide and its bioactivity on colitis via improving the intestinal barrier and modifying the gut microbiota

Gong, H., Gan, X., Qin, B., Chen, J., Zhao, Y., Qiu, B., Chen, W., Yu, Y., Shi, S., Li, T., et al. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.121669 · Cited by 150 · see citing works

Risk of Arterial Thrombotic Events in Inflammatory Bowel Disease

Picco, M. F. (2009) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(09)79360-2 · Cited by 147 · see citing works

Anti-Inflammatory and Immunosuppressive Effects of the A2AAdenosine Receptor

Milne, G. R., & Palmer, T. M. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.22 · Cited by 139 · see citing works

Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression

Wang, Z., Jin, H., Xu, R., Mei, Q., & Fan, D. (2009) · Experimental & Molecular Medicine · doi:10.3858/emm.2009.41.10.078 · Cited by 131 · see citing works

Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease

Craig, C. F., Filippone, R. T., Stavely, R., Bornstein, J. C., Apostolopoulos, V., & Nurgali, K. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02354-1 · Cited by 124 · see citing works

Anti-inflammatory effects and chemical study of a flavonoid-enriched fraction from adlay bran

Chen, H.-J., Chung, C.-P., Chiang, W., & Lin, Y. (2010) · Food Chemistry · doi:10.1016/j.foodchem.2010.12.074 · Cited by 130 · see citing works

Interleukin-6 Mediates the Platelet Abnormalities and Thrombogenesis Associated with Experimental Colitis

Senchenkova, E. Y., Komoto, S., Russell, J., Almeida-Paula, L. D., Yan, L.-S., Zhang, S., & Granger, D. N. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.03.014 · Cited by 125 · see citing works

Chemopreventive effect of oleuropein in colitis‐associated colorectal cancer in c57bl/6 mice

Giner, E., Recio, M. C., Rı́os, J. L., Cerdá‐Nicolás, M., & Giner, R. M. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500605 · Cited by 124 · see citing works

L-cysteine supplementation attenuates local inflammation and restores gut homeostasis in a porcine model of colitis

Kim, C. J., Kovacs-Nolan, J., Yang, C., Archbold, T. L., Fan, M., & Mine, Y. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.05.018 · Cited by 122 · see citing works

Monocyte-derived IL-6 programs microglia to rebuild damaged brain vasculature

Choi, B., Johnson, K. R., Maric, D., & McGavern, D. B. (2023) · Nature Immunology · doi:10.1038/s41590-023-01521-1 · Cited by 121 · see citing works

Interleukin-6 trans-signaling in inflammatory bowel disease.

Mitsuyama, K., Sata, M., & Rose-John, S. (2006) · Cytokine & growth factor reviews · doi:10.1016/j.cytogfr.2006.09.003 · Cited by 122 · see citing works

The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target

Verma, A., Pittala, S., Alhozeel, B., Shteinfer‐Kuzmine, A., Ohana, E., Gupta, R., Chung, J. H., & Shoshan‐Barmatz, V. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.06.024 · Cited by 116 · see citing works

Biological characteristics of IL-6 and related intestinal diseases

Guo, Y., Wang, B., Wang, T., Gao, L., Yang, Z., Wang, F.-F., Shang, H., Hua, R., & Xu, J. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.51362 · Cited by 114 · see citing works

Advances in the treatment of inflammatory bowel disease: Focus on polysaccharide nanoparticulate drug delivery systems

Hadji, H., & Bouchemal, K. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114101 · Cited by 112 · see citing works

Comorbidity of Allergic and Autoimmune Diseases Among Patients With ADHD

Chen, M., Su, T., Chen, Y.-S., Hsu, J.-W., Huang, K., Chang, W.-H., Chen, T., & Bai, Y. (2013) · Journal of Attention Disorders · doi:10.1177/1087054712474686 · Cited by 112 · see citing works

IL-6 promotes T cell proliferation and expansion under inflammatory conditions in association with low-level RORγt expression

Li, B.-F., Jones, L., & Geiger, T. (2018) · Journal of Immunology · doi:10.4049/jimmunol.1800016 · Cited by 106 · see citing works

Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation

Chatterjee, P. K., Al‐Abed, Y., Sherry, B. A., & Metz, C. N. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00160.2009 · Cited by 111 · see citing works

Mechanisms by Which the Gut Microbiota Influences Cytokine Production and Modulates Host Inflammatory Responses

de Almeida, V. M., Galvão, I., & Vieira, A. T. (2019) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2019.0011 · Cited by 108 · see citing works

Glabridin, a functional compound of liquorice, attenuates colonic inflammation in mice with dextran sulphate sodium-induced colitis

Kwon, H.-S., Oh, S.-M., & Kim, J.-K. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03539.x · Cited by 107 · see citing works

Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects

Kast, R. E., & Foley, K. F. (2007) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2006.00760.x · Cited by 101 · see citing works

Enteric Nervous System Regulation of Intestinal Stem Cell Differentiation and Epithelial Monolayer Function

Puzan, M. L., Hosic, S., Ghio, C., & Koppes, A. N. (2018) · Scientific Reports · doi:10.1038/s41598-018-24768-3 · Cited by 100 · see citing works

Dietary cranberry suppressed colonic inflammation and alleviated gut microbiota dysbiosis in dextran sodium sulfate-treated mice

Cai, X., Han, Y., Gu, M., Song, M., Wu, X., Li, Z., Li, F., Goulette, T., & Xiao, H. (2019) · Food & Function · doi:10.1039/c9fo01537j · Cited by 100 · see citing works

Soy-Derived Di- and Tripeptides Alleviate Colon and Ileum Inflammation in Pigs with Dextran Sodium Sulfate-Induced Colitis3

Young, D. D., Ibuki, M., Nakamori, T., Fan, M. Z., & Mine, Y. (2011) · Journal of Nutrition · doi:10.3945/jn.111.149104 · Cited by 100 · see citing works

Animal Models of Colitis‐Associated Carcinogenesis

Kanneganti, M., Mino-Kenudson, M. A., & Mizoguchi, E. (2011) · BioMed Research International · doi:10.1155/2011/342637 · Cited by 97 · see citing works

Modulation of cytokine patterns and microbiome during pregnancy in IBD

van der Giessen, J., Binyamin, D., Belogolovski, A., Frishman, S., Tenenbaum-Gavish, K., Hadar, E., Louzoun, Y., Peppelenbosch, M. P., van der Woude, C. J., Koren, O., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318263 · Cited by 99 · see citing works

Heart failure and anti tumor necrosis factor-alpha in systemic chronic inflammatory diseases

Sinagra, E., Perricone, G., Romano, C., & Cottone, M. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2012.12.015 · Cited by 95 · see citing works

Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells.

Eurich, K., Segawa, M., Toei-Shimizu, S., & Mizoguchi, E. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5249 · Cited by 89 · see citing works

Yogurt starter cultures of Streptococcus thermophilus and Lactobacillus bulgaricus ameliorate symptoms and modulate the immune response in a mouse model of dextran sulfate sodium-induced colitis

Wasilewska, E. M., Złotkowska, D., & Wróblewska, B. (2018) · Journal of Dairy Science · doi:10.3168/jds.2018-14520 · Cited by 94 · see citing works

Polysaccharides From Chrysanthemum morifolium Ramat Ameliorate Colitis Rats via Regulation of the Metabolic Profiling and NF-κ B/TLR4 and IL-6/JAK2/STAT3 Signaling Pathways

Tao, J., Duan, J., Zhang, W., Jiang, S., Guo, J., & Wei, D. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00746 · Cited by 91 · see citing works

Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development

Azer, S. A. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32835b5803 · Cited by 91 · see citing works

JAK inhibition in inflammatory bowel disease

Olivera, P. A., Danese, S., & Peyrin‐Biroulet, L. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1291342 · Cited by 89 · see citing works

Adiponectin blocks multiple signaling cascades associated with leptin‐induced cell proliferation in ApcMin/+ colon epithelial cells

Fenton, J. I., Birmingham, J., Hursting, S. D., & Hord, N. G. (2008) · International Journal of Cancer · doi:10.1002/ijc.23436 · Cited by 89 · see citing works

Down-regulation of IL-6 production by astaxanthin via ERK-, MSK-, and NF-κB-mediated signals in activated microglia

Kim, Y. H., Koh, H.-K., & Kim, D. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.09.007 · Cited by 88 · see citing works

Pre-analytical and biological variability in circulating interleukin 6 in healthy subjects and patients with rheumatoid arthritis

Knudsen, L. S., Christensen, I. J., Lottenburger, T., Svendsen, M. N., Nielsen, H. J., Nielsen, L., Hørslev‐Petersen, K., Jensen, J. B., Kollerup, G., & Johansen, J. S. (2008) · Biomarkers · doi:10.1080/13547500701615017 · Cited by 86 · see citing works

MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel disease

Banerjee, S., Oneda, B., Yap, L. M., Jewell, D. P., Matters, G. L., Fitzpatrick, L. R., Seibold, F., Sterchi, E. E., Ahmad, T., Lottaz, D., et al. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.3 · Cited by 85 · see citing works

Molecular mechanisms linking adipokines to obesity-related colon cancer: focus on leptin

Drew, J. E. (2011) · Proceedings of The Nutrition Society · doi:10.1017/s0029665111003259 · Cited by 84 · see citing works

IL-17A in the tumor microenvironment of the human colorectal adenoma–carcinoma sequence

Cui, G., Yuan, A., Goll, R., & Florholmen, J. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.725089 · Cited by 84 · see citing works

Flaxseed oligosaccharides alleviate DSS-induced colitis through modulation of gut microbiota and repair of the intestinal barrier in mice

Xu, Z., Chen, W., Deng, Q., Huang, Q., Wang, X., Yang, C., & Huang, F. (2020) · Food & Function · doi:10.1039/d0fo01105c · Cited by 83 · see citing works

The unrecognized occupational relevance of the interaction between engineered nanomaterials and the gastro-intestinal tract: a consensus paper from a multidisciplinary working group

Pietroiusti, A., Bergamaschi, E., Campagna, M., Campagnolo, L., Palma, G. D., Iavicoli, S., Leso, V., Magrini, A., Miragoli, M., Pedata, P., et al. (2017) · Particle and Fibre Toxicology · doi:10.1186/s12989-017-0226-0 · Cited by 82 · see citing works

The impact of the level and distribution of methyl-esters of pectins on TLR2-1 dependent anti-inflammatory responses

Beukema, M., Jermendi, É., van den Berg, M. A., Faas, M. M., Schols, H. A., & de Vos, P. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117093 · Cited by 82 · see citing works

Natural polysaccharides protect against diet-induced obesity by improving lipid metabolism and regulating the immune system

Tang, C., Wang, Y., Chen, D., Zhang, M., Xu, J., Chen, X., Liu, J., Kan, J., & Jin, C. (2023) · Food Research International · doi:10.1016/j.foodres.2023.113192 · Cited by 88 · see citing works

Colorectal cancer chemoprevention by 2 β‐cyclodextrin inclusion compounds of auraptene and 4′‐geranyloxyferulic acid

Tanaka, T., de Azevedo, M. B. M., Durán, N., Alderete, J. B., Epifano, F., Genovese, S., Tanaka, M., Tanaka, T., & Curini, M. (2009) · International Journal of Cancer · doi:10.1002/ijc.24833 · Cited by 81 · see citing works

Dietary manipulation of the gut microbiome in inflammatory bowel disease patients: Pilot study

Olendzki, B. C., Bucci, V., Cawley, C., Maserati, R., McManus, M. M., Olednzki, E., Madziar, C., Chiang, D., Ward, D. V., Pellish, R. S., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2046244 · Cited by 77 · see citing works

Embelin Reduces Colitis-Associated Tumorigenesis through Limiting IL-6/STAT3 Signaling

Dai, Y., Jiao, H., Teng, G., Wang, W., Zhang, R., Wang, Y., Hebbard, L., George, J., & Qiao, L. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0378 · Cited by 78 · see citing works

Dimethyl sulfoxide (DMSO) attenuates the inflammatory response in the in vitro intestinal Caco-2 cell model

Hollebeeck, S., Raas, T., Piront, N., Schneider, Y., Toussaint, O., Larondelle, Y., & During, A. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.08.010 · Cited by 75 · see citing works

Depression in individuals who subsequently develop inflammatory bowel disease: a population-based nested case–control study

Blackwell, J., Saxena, S., Petersen, I., Hotopf, M., Creese, H., Bottle, A., Alexakis, C., & Pollok, R. C. (2021) · Gut · doi:10.1136/gutjnl-2020-322308 · Cited by 73 · see citing works

Baicalin alleviates TNBS‑induced colitis by inhibiting PI3K/AKT pathway activation

Zhu, L., Shen, H., Gu, P., Liu, Y., Zhang, L., & Cheng, J. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8718 · Cited by 71 · see citing works

Distinct roles of histamine H1- and H2-receptor signaling pathways in inflammation-associated colonic tumorigenesis

Shi, Z., Fultz, R., Engevik, M. A., Gao, C., Hall, A., Major, A. M., Mori–Akiyama, Y., & Versalovic, J. A. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00212.2018 · Cited by 68 · see citing works

STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancer.

Nguyen, A. V., Wu, Y.-Y., & Lin, E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i30.10279 · Cited by 68 · see citing works

The Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals

Koblansky, A. A., Truax, A. D., Liu, R., Montgomery, S. A., Ding, S., Wilson, J. E., Brickey, W. J., Mühlbauer, M., McFadden, R.-M. T., Hu, P., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.064 · Cited by 68 · see citing works

Effects of Bacillus subtilis on Epithelial Tight Junctions of Mice with Inflammatory Bowel Disease

Gong, Y., Li, H., & Li, Y. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2015.0030 · Cited by 67 · see citing works

STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease

Lu, S. X., Alpdoğan, Ö., Lin, J. T., BALDERAS, R. S., Campos‐González, R., Wang, X., Gao, G., Suh, D. Y., King, C. G., Chow, M., et al. (2008) · Blood · doi:10.1182/blood-2008-03-147322 · Cited by 66 · see citing works

Gastrointestinal cancers in inflammatory bowel disease: An update with emphasis on imaging findings

Barral, M., Dohan, A. J. J., Allez, M., Boudiaf, M., Camus, M., Laurent, V., Hoeffel, C. C., & Soyer, P. A. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.08.005 · Cited by 63 · see citing works

Platelet Activation and Platelet-leukocyte Aggregation Elicited in Experimental Colitis Are Mediated by Interleukin-6

Yan, S. L.-S., Russell, J., & Granger, D. N. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000440614.83703.84 · Cited by 62 · see citing works

Th9 cells in inflammatory bowel diseases

Weigmann, B., & Neurath, M. F. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0603-z · Cited by 63 · see citing works

Suppression of experimental colitis in mice by CD11c+ dendritic cells

Qualls, J. E., Tuna, H., Kaplan, A. M., & Cohen, D. A. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20733 · Cited by 61 · see citing works

Subcellular proteomics of cell differentiation: Quantitative analysis of the plasma membrane proteome of Caco‐2 cells

Pshezhetsky, A. V., Fedjaev, M., ASHMARINA, L. I., Mazur, A. M., Budman, L. I., Sinnett, D., Labuda, D., Beaulieu, J., Ménard, D., Nifant'ev, I. E., et al. (2007) · PROTEOMICS · doi:10.1002/pmic.200600956 · Cited by 60 · see citing works

Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice

Mañé, J., Lorén, V., Pedrosa, E., Ojanguren, I., Xaus, J., Cabré, E., Domènech, E., & Gassull, M. A. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20908 · Cited by 60 · see citing works

Biological activity of terpene compounds produced by biotechnological methods

Paduch, R., Trytek, M., Król, S. K., Kud, J., Frant, M. P., Kandefer‐Szerszeń, M., & Fiedurek, J. (2016) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1103753 · Cited by 59 · see citing works

Physical Activity and Gastrointestinal Cancer Prevention

Wolin, K. Y., & Tuchman, H. (2010) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-04231-7_4 · Cited by 58 · see citing works

RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients

Cross-Knorr, S., Lu, S., Perez, K., Guevara, S., Brilliant, K. E., Pisano, C., Quesenberry, P. J., Resnick, M. B., & Chatterjee, D. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-463 · Cited by 58 · see citing works

The anti-inflammatory activity of peptides from simulated gastrointestinal digestion of preserved egg white in DSS-induced mouse colitis

Zhang, M., Zhao, Y., Wu, N., Yao, Y., Xu, M., Du, H., & Tu, Y. (2018) · Food & Function · doi:10.1039/c8fo01939h · Cited by 56 · see citing works

Interferon regulatory factor signaling in autoimmune disease

Matta, B., Song, S., Li, D., & Barnes, B. J. (2017) · Cytokine · doi:10.1016/j.cyto.2017.02.006 · Cited by 55 · see citing works

The Role of β-Carotene in Colonic Inflammation and Intestinal Barrier Integrity

Cheng, J., Balbuena, E., Miller, B., & Eroglu, A. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.723480 · Cited by 54 · see citing works

CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases

Tan, Y., Zhao, M., Xiang, B., Chang, C., & Lu, Q. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8470-2 · Cited by 54 · see citing works

MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma

Li, X., Nie, J., Mei, Q., & Han, W. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i23.5317 · Cited by 54 · see citing works

Suppression of colitis‐associated carcinogenesis through modulation of IL‐6/STAT3 pathway by balsalazide and VSL#3

Do, E., Hwang, S. W., Kim, S., Ryu, Y., Cho, E. A., Chung, E., Park, S., Lee, H. J., Byeon, J., Ye, B. D., et al. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13280 · Cited by 52 · see citing works

Nicotine protects against DSS colitis through regulating microRNA-124 and STAT3

Qin, Z., Wan, J.-J., Sun, Y., Wu, T., Wang, P., Du, P., Su, D., Yang, Y., & Liu, X. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1473-5 · Cited by 51 · see citing works

Is Adipose Tissue Inflammation the Culprit of Obesity‐Associated Comorbidities?

Turner, L., Wanasinghe, A. I., Brunori, P., & Santosa, S. (2025) · Obesity Reviews · doi:10.1111/obr.13956 · Cited by 58 · see citing works

Balance of meprin A and B in mice affects the progression of experimental inflammatory bowel disease

Banerjee, S., Jin, G., Bradley, S. G., Matters, G. L., Gailey, R. D., Crisman, J. M., & Bond, J. S. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00504.2009 · Cited by 49 · see citing works

Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs

Swaroop, A. K., Negi, P., Kar, A., Mariappan, E., Natarajan, J., Namboori, P. K. K., & Selvaraj, J. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.12.007 · Cited by 48 · see citing works

Network modelling reveals the mechanism underlying colitis-associated colon cancer and identifies novel combinatorial anti-cancer targets

Lu, J., Zeng, H., Liang, Z. T., Chen, L., Zhang, L.-Y., Zhang, H., Liu, H., Jiang, H., Shen, B., Huang, M., et al. (2015) · Scientific Reports · doi:10.1038/srep14739 · Cited by 48 · see citing works

Interleukin-6 is linked to longitudinal rates of cortical thinning in aging

McCarrey, A. C., Pacheco, J. L., Carlson, O. D., Egan, J. M., Thambisetty, M., An, Y., Ferrucci, L., & Resnick, S. M. (2014) · Translational Neuroscience · doi:10.2478/s13380-014-0203-0 · Cited by 48 · see citing works

The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer

Bocchetti, M., Ferraro, M. G., Ricciardiello, F., Ottaiano, A., Luce, A., Cossu, A. M., Scrima, M., Leung, W. Y., Abate, M., Stiuso, P., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083967 · Cited by 48 · see citing works

Serum galectins as potential biomarkers of inflammatory bowel diseases

Yu, T., Dodd, S. R., Yu, L., & Subramanian, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227306 · Cited by 46 · see citing works

Interleukin-6 Trans-Signaling and Colonic Cancer Associated with Inflammatory Bowel Disease

Rose‐John, S., Mitsuyama, K., Matsumoto, S., Thaiss, W. M., & Scheller, J. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788489140 · Cited by 70 · see citing works

Signaling Molecules: The Pathogenic Role of the IL-6/STAT-3 Trans Signaling Pathway in Intestinal Inflammation and in Colonic Cancer

Atreya, R. N., & Neurath, M. (2008) · Current Drug Targets · doi:10.2174/138945008784221116 · Cited by 109 · see citing works

Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development

Waldner, M. J., & Neurath, M. F. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2013.12.003 · Cited by 193 · see citing works

Interleukin-6 trans-signaling in inflammatory bowel disease.

Mitsuyama, K., Sata, M., & Rose-John, S. (2006) · Cytokine & growth factor reviews · doi:10.1016/j.cytogfr.2006.09.003 · Cited by 122 · see citing works

Il-6 signaling in inflammatory bowel disease: Pathophysiological role and clinical relevance

Mudter, J., & Neurath, M. F. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20148 · Cited by 438 · see citing works